Evidence map›Paper›PMID 37401812›Full record

ReviewJournal of cutaneous medicine and surgery

The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications.

François Lagacé, Kathleen D'Aguanno, Connor Prosty, Alexandra Laverde-Saad, Leila Cattelan, Lydia Ouchene, Sarah Oliel, Genevieve Genest, Philip Doiron, Vincent Richer and 8 more

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of cutaneous medicine and surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Real-World Data on Severe Cutaneous Adverse Reactions to Drugs.Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  6. Observational
  7. Review
  8. Article
  9. UTX (KDM6A) promotes differentiation noncatalytically in somatic self-renewing epithelia.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Antibiotics (Basel, Switzerland) · 2024
    Review
  15. An Overview of the Biological Complexity of Vitiligo.Oxidative medicine and cellular longevity · 2024
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

François LagacéDivision of Dermatology, Faculty of Medicine, McGill University, Montréal, Québec, Canada.ORCID 0000-0002-9033-2302
Kathleen D'AguannoFaculty of Medicine, McGill University, Montréal, Québec, Canada.ORCID 0000-0002-0332-0320
Connor ProstyFaculty of Medicine, McGill University, Montréal, Québec, Canada.ORCID 0000-0001-6790-220X
Alexandra Laverde-SaadDivision of Dermatology, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
Leila CattelanDivision of Dermatology, Faculty of Medicine, McGill University, Montréal, Québec, Canada.ORCID 0000-0002-7703-1476
Lydia OucheneDivision of Dermatology, Faculty of Medicine, McGill University, Montréal, Québec, Canada.ORCID 0000-0002-1556-5851
Sarah OlielFaculty of Medicine, McGill University, Montréal, Québec, Canada.
Genevieve GenestDivision of Allergy and Immunology, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
Philip DoironDivision of Dermatology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-7249-8341
Vincent RicherDepartment of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.
Abdulhadi JfriDepartment of Dermatology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Elizabeth O'BrienDivision of Dermatology, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
Philippe LefrançoisDivision of Dermatology, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
Mathieu PowellDivision of Dermatology, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
Linda MoreauDivision of Dermatology, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
Ivan V LitvinovDivision of Dermatology, Faculty of Medicine, McGill University, Montréal, Québec, Canada.ORCID 0000-0003-0562-4675
Anastasiya MuntyanuDivision of Dermatology, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
Elena NetchiporoukDivision of Dermatology, Faculty of Medicine, McGill University, Montréal, Québec, Canada.ORCID 0000-0002-6692-7787
McGill University · CABrigham and Women's Hospital · USUniversity of British Columbia · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSex and gender have increasingly been recognized as significant risk factors for many diseases, including dermatological conditions. Historically, sex and gender have often been grouped together as a single risk factor in the scientific literature. However, both may have a distinct impact on disease incidence, prevalence, clinical presentation, severity, therapeutic response, and associated psychological distress. OBJECTIVES AND PROJECT DESCRIPTION: The mechanisms that underlie differences in skin diseases between males, females, men, and women remain largely unknown. The specific objectives of this review paper are:To highlight the biological differences between males and females (sex), as well as the sociocultural differences between men and women (gender) and how they impact the integumentary system.To perform a literature review to identify important sex- and gender-related epidemiological and clinical differences for various skin conditions belonging to a range of disease categories and to discuss possible biological and sociocultural factors that could explain the observed differences.To discuss dermatological skin conditions and gender-affirming treatments within the transgender community, a population of individuals who have a gender identity which is different than the gender identity they were assigned at birth. FUTURE IMPACT: With the rising number of individuals that identify as non-binary or transgender within our increasingly diverse communities, it is imperative to recognize gender identity, gender, and sex as distinct entities. By doing so, clinicians will be able to better risk-stratify their patients and select treatments that are most aligned with their values. To our knowledge, very few studies have separated sex and gender as two distinct risk factors within the dermatology literature. Our article also has the potential to help guide future prevention strategies that are patient-tailored rather than using a universal approach.

Indexed as

DermatologyTransgender PersonsFemaleGender IdentityHumansMaleRisk Factorsdermatologygenderincidencesexskin condition

Identifiers

PMID37401812
PMCPMC10486181
OpenAlexW4383058517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.